{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}],"units":"Participants"}],"groups":[{"description":"Bendamustine 70 mg/m2, ABT-888 50 mg","id":"OG000","title":"Dose Level 1: Bendamustine 70 mg/m2, ABT-888 50 mg"},{"description":"Bendamustine 90 mg/m2, ABT-888 50 mg","id":"OG001","title":"Dose Level 2: Bendamustine 90 mg/m2, ABT-888 50 mg"},{"description":"Bendamustine 90 mg/m2, ABT-888 100 mg BID","id":"OG002","title":"Dose Level 3: Bendamustine 90 mg/m2, ABT-888 100 mg BID"},{"description":"Bendamustine 90 mg/m2, ABT-888 150 mg BID","id":"OG003","title":"Dose Level 4: Bendamustine 90 mg/m2, ABT-888 150 mg BID"},{"description":"Bendamustine 90 mg/m2, ABT-888 200 mg BID","id":"OG004","title":"Dose Level 5: Bendamustine 90 mg/m2, ABT-888 200 mg BID"},{"description":"Bendamustine 90 mg/m2, ABT-888 300 mg BID","id":"OG005","title":"Dose Level 6: Bendamustine 90 mg/m2, ABT-888 300 mg BID"},{"description":"Bendamustine 90 mg/m2, ABT-888 400 mg BID","id":"OG006","title":"Dose Level 7: Bendamustine 90 mg/m2, ABT-888 400 mg BID"}],"populationDescription":"Data were not collected","reportingStatus":"POSTED","timeFrame":"From the first documented response to the first documented progression or death, assessed up to 30 days post-treatment","title":"Duration of Remission (Phase IIa)","type":"SECONDARY"}